Gore Launches Clinical Quality Improvement (CQI) Project of New Hernia Repair Device
New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial
New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms
New Campaign Will Employ Awareness, Community Outreach, and Patient Screening to Fight AAA
Expanded Treatment Options for Abdominal Aortic Aneurysms Provide More Patients with Access to Minimally Invasive Endovascular Repair
Multi-Center Study to Assess Safety and Effectiveness of GORE® EXCLUDER® Iliac Branch Endoprosthesis for Treatment of Common Iliac Artery Aneurysms (CIAA) or Aorto-Iliac Aneurysms (AIA)
First Successful Implants Completed in Italy and the United Kingdom, Providing Endovascular Repair to Iliac Arteries
Device offers first and only complete “off-the-shelf” endovascular system specifically designed to treat aortic aneurysms involving visceral branch vessels
Partnership latest step in Gore’s ongoing commitment to improve quality of care for hernia patients